|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Marusyk A and Polyak K: Tumor
heterogeneity: Causes and consequences. Biochim Biophys Acta.
1805:105–117. 2010.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Reis-Filho JS and Pusztai L: Gene
expression profiling in breast cancer: Classification,
prognostication, and prediction. Lancet. 378:1812–1823.
2011.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Bahnassy A, Mohanad M, Ismail MF, Shaarawy
S, El-Bastawisy A and Zekri AR: Molecular biomarkers for prediction
of response to treatment and survival in triple negative breast
cancer patients from Egypt. Exp Mol Pathol. 99:303–311.
2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Garrido-Castro AC, Lin NU and Polyak K:
Insights into molecular classifications of triple-negative breast
cancer: Improving patient selection for treatment. Cancer Discov.
9:176–198. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Abramson VG, Lehmann BD, Ballinger TJ and
Pietenpol JA: Subtyping of triple-negative breast cancer:
Implications for therapy. Cancer. 121:8–16. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Jhan JR and Andrechek ER: Triple-negative
breast cancer and the potential for targeted therapy.
Pharmacogenomics. 18:1595–1609. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Damaskos C, Garmpi A, Nikolettos K,
Vavourakis M, Diamantis E, Patsouras A, Farmaki P, Nonni A,
Dimitroulis D, Mantas D, et al: Triple-negative breast cancer: The
progress of targeted therapies and future tendencies. Anticancer
Res. 39:5285–5296. 2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Langfelder P and Horvath S: WGCNA: An R
package for weighted correlation network analysis. BMC
Bioinformatics. 9(559)2008.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Liu H, Sun Y, Tian H, Xiao X, Zhang J,
Wang Y and Yu F: Characterization of long non-coding RNA and
messenger RNA profiles in laryngeal cancer by weighted gene
co-expression network analysis. Aging (Albany NY). 11:10074–10099.
2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Yang J, Li C, Zhou J, Liu X and Wang S:
Identification of prognostic genes in leiomyosarcoma by gene
co-expression network analysis. Front Genet.
10(1408)2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wang WJ, Guo CA, Li R, Xu ZP, Yu JP, Ye Y,
Zhao J, Wang J, Wang WA, Zhang A, et al: Long non-coding RNA CASC19
is associated with the progression and prognosis of advanced
gastric cancer. Aging (Albany NY). 11:5829–5847. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Burstein MD, Tsimelzon A, Poage GM,
Covington KR, Contreras A, Fuqua SA, Savage MI, Osborne CK,
Hilsenbeck SG, Chang JC, et al: Comprehensive genomic analysis
identifies novel subtypes and targets of triple-negative breast
cancer. Clin Cancer Res. 21:1688–1698. 2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Clarke C, Madden SF, Doolan P, Aherne ST,
Joyce H, O'Driscoll L, Gallagher WM, Hennessy BT, Moriarty M, Crown
J, et al: Correlating transcriptional networks to breast cancer
survival: A large-scale coexpression analysis. Carcinogenesis.
34:2300–2308. 2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Hatzis C, Pusztai L, Valero V, Booser DJ,
Esserman L, Lluch A, Vidaurre T, Holmes F, Souchon E, Wang H, et
al: A genomic predictor of response and survival following
taxane-anthracycline chemotherapy for invasive breast cancer. JAMA.
305:1873–1881. 2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kim YJ, Sung M, Oh E, Vrancken MV, Song
JY, Jung K and Choi YL: Engrailed 1 overexpression as a potential
prognostic marker in quintuple-negative breast cancer. Cancer Biol
Ther. 19:335–345. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Castilla M, López-García MA, Atienza MR,
Rosa-Rosa JM, Díaz-Martín J, Pecero ML, Vieites B, Romero-Pérez L,
Benítez J, Calcabrini A and Palacios J: VGLL1 expression is
associated with a triple-negative basal-like phenotype in breast
cancer. Endocr Relat Cancer. 21:587–599. 2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Lim HK, Rahim AB, Leo VI, Das S, Lim TC,
Uemura T, Igarashi K, Common J and Vardy LA: Polyamine regulator
AMD1 promotes cell migration in epidermal wound healing. J Invest
Dermatol. 138:2653–2665. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zabala-Letona A, Arruabarrena-Aristorena
A, Martín-Martín N, Fernandez-Ruiz S, Sutherland JD, Clasquin M,
Tomas-Cortazar J, Jimenez J, Torres I, Quang P, et al:
mTORC1-dependent AMD1 regulation sustains polyamine metabolism in
prostate cancer. Nature. 547:109–113. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Stone L: Prostate cancer: Mechanisms of
cancer metabolism: mTORC1 mediates AMD1. Nat Rev Urol.
14(454)2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Chen K, Liu H, Liu Z, Luo S, Patz EF Jr,
Moorman PG, Su L, Shen S, Christiani DC and Wei Q: Genetic variants
in RUNX3, AMD1 and MSRA in the methionine metabolic pathway and
survival in nonsmall cell lung cancer patients. Int J Cancer.
145:621–631. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Xu L, You X, Cao Q, Huang M, Hong LL, Chen
XL, Lei L, Ling ZQ and Chen Y: Polyamine synthesis enzyme AMD1 is
closely associated with tumorigenesis and prognosis of human
gastric cancers. Carcinogenesis. 41:214–222. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Peluffo G, Subedee A, Harper NW, Kingston
N, Jovanović B, Flores F, Stevens LE, Beca F, Trinh A, Chilamakuri
CS, et al: EN1 is a transcriptional dependency in triple-negative
breast cancer associated with brain metastasis. Cancer Res.
79:4173–4183. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Bell D, Bell A, Roberts D, Weber RS and
El-Naggar AK: Developmental transcription factor EN1-a novel
biomarker in human salivary gland adenoid cystic carcinoma. Cancer.
118:1288–1292. 2012.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Miura K, Akashi T, Ando N, Ayabe S,
Kayamori K, Namiki T and Eishi Y: Homeobox transcriptional factor
engrailed homeobox 1 is expressed specifically in normal and
neoplastic sweat gland cells. Histopathology. 72:1199–1208.
2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zecca M and Struhl G: A feed-forward
circuit linking wingless, fat-dachsous signaling, and the
warts-hippo pathway to drosophila wing growth. PLoS Biol.
8(e1000386)2010.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Mori S, Takeuchi T, Ishii Y and Kukimoto
I: The transcriptional cofactor VGLL1 drives transcription of human
papillomavirus early genes via TEAD1. J Virol. 94:e01945–e01919.
2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kim BK, Cheong JH, Im JY, Ban HS, Kim SK,
Kang MJ, Lee J, Kim SY, Park KC, Paik S and Won M:
PI3K/AKT/β-catenin signaling regulates vestigial-like 1 which
predicts poor prognosis and enhances malignant phenotype in gastric
cancer. Cancers (Basel). 11(1923)2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kundishora AJ, Reeves BC, Nelson-Williams
C, Hong CS, Gopal PP, Snuderl M, Kahle KT and Erson-Omay EZ: Novel
EWSR1-VGLL1 fusion in a pediatric neuroepithelial neoplasm. Clin
Genet. 97:791–792. 2020.PubMed/NCBI View Article : Google Scholar
|
